As Lina Khan, chair of the Federal Trade Commission, ends her tenure this week the FTC posted a second report in six months ...

Cigna executives kicked off Thursday’s earnings call by responding to pharmacy benefit manager critics with a number of reforms.

Longstanding claims that one of the reasons for high drug prices in the US is the actions of pharmacy benefit management (PBM) companies – the middlemen in the supply chain – are being ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

The Iowa Pharmacy Association is calling for reform from Iowa lawmakers after 29 pharmacies closed last year, including some ...

selling a version of Humira for $584 for cash-paying customers without involving a PBM. Typically, PBMs are the entities in the prescription drug supply chain that negotiate net prices and ...

(The largest, CVS Caremark, is not included in the suit.) PBM are the middlemen of the pharmaceutical supply chain. As third-party intermediaries they negotiate with manufacturers, pharmacies, ...